Symbiox Investment approves FY26 results, fixes Sept 28 AGM date
- Symbiox Investment approved FY25-26 Director Report and financial statements
- 47th AGM scheduled for September 28, 2026, via video conference
- Share transfer books closed from September 22 to September 28, 2026
- Remote e-voting period runs from September 25 to September 27, 2026

*this image is generated using AI for illustrative purposes only.
Symbiox Investment & Trading Co Ltd has approved its annual report and financial statements for FY25-26. The Board of Directors also scheduled the company’s 47th Annual General Meeting for September 28, 2026.
The board meeting concluded on August 26, 2026, at the company’s registered office in Kolkata. During the session, directors approved the Director Report, Management Discussion and Analysis (MD&A), and Corporate Governance Report for the fiscal year ending March 31, 2026.
AGM Schedule and Logistics
The 47th Annual General Meeting will be held on Monday, September 28, 2026, at 1:30 pm. The event will be conducted through Video Conferencing or Other Audio-Visual Means (OAVM). To facilitate this, the Register of Members and share transfer books will remain closed from September 22, 2026, to September 28, 2026.
E-Voting Details
Shareholders are eligible to vote remotely on resolutions set out in the AGM notice. The cutoff date for determining voting eligibility is Monday, September 21, 2026. The remote e-voting window operates as follows:
- Commencement: 9:00 am on Friday, September 25, 2026
- Closure: 5:00 pm on Sunday, September 27, 2026
Mr. Akhil Agarwal, a practicing Company Secretary, has been appointed as the scrutinizer to oversee the e-voting process and ensure transparency.
Compliance Updates
The Board also reviewed the status of statutory registers maintained under the Companies Act, 2013. The company notified BSE, CSE, and MSEI regarding these outcomes pursuant to SEBI listing regulations.
Historical Stock Returns for Symbiox Investment & Trading
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.38% | +7.00% | +25.88% | +24.42% | -22.18% | 0.0% |
What specific financial performance metrics or strategic initiatives were highlighted in the approved FY25-26 Management Discussion and Analysis?
How might the transition to a fully virtual AGM via OAVM impact shareholder engagement levels and voting participation rates for Symbiox Investment & Trading Co Ltd?
Are there any pending regulatory observations from SEBI regarding the statutory registers that could influence future compliance strategies or operational adjustments?






























